Corporate Profile

Hyperfine, Inc. is the groundbreaking medical device company that created Swoop®, the world’s first FDA-cleared point-of-care MRI system. Hyperfine designed Swoop to enable rapid diagnoses and treatment for every patient regardless of income, resources, or location, pushing the boundaries of conventional imaging technology and expanding patient access to life-saving care. The Swoop Portable MR Imaging System™ produces high-quality images at a low magnetic field strength, allowing clinicians to quickly scan, diagnose, and treat patients in various clinical settings. Swoop can be wheeled directly to the patient’s bedside, plugged into a standard electrical wall outlet, and controlled by an iPad®. Designed as a complementary system to conventional MRIs at a fraction of the cost, Swoop captures images in minutes, providing critical decision-making capabilities in emergency departments, operating rooms outside the sterile field, and intensive care units, among others.
Hyperfine Swoop COB LBL

Stock Information

Stock Chart

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Upcoming EventsUpcoming Events

Featured ReportsFeatured Reports

More information is coming soon.
View All

News Releases

21 Mar '24
GUILFORD, Conn. , March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced fourth quarter and...